Article

Company unveils latest generation of assistive device for the legally blind

Author(s):

eSight is previewing its eSight Go, a wearable device that allows users to gain a level of independence.

According to the company, eSight will be available on the market starting in Q4 2023.

According to the company, eSight will be available on the market starting in Q4 2023.

eSight today announces the launch of its latest innovation in assistive technology, eSight Go.

According to a news release from the company, the wearable device offers improved visual clarity, lightweight design and expansive field of view, helping those with central vision loss gain independence in their everyday life.

“We’ve spent the past year vastly improving the capacity and design of our digital eyewear, not only to help enhance vision for our visually impaired users, but so they can enjoy an enriched and fulfilling livelihood in the most seamless way possible,” eSight Director of Product Marketing Roland Mattern said in the news release. “We gathered feedback from our eSight 4 users and coaches to thoughtfully craft the best device possible that is sleek, lightweight and comfortable for everyday use. We look forward to connecting with qualified candidates and changing lives for those living with central vision loss.”

Used by thousands of people across the globe with more than 20 different eye conditions, eSight devices use a combination of hardware and software to enhance vision through a nimble, wearable design that does not restrict a wearer’s full periphery. eSight Go is designed for 100 percent mobility retention, allowing people to use the technology while at school, work, home and enjoying time with friends and family.

Comparable to eSight 4, eSight Go utilizes best-match camera and lens technology to project a superior image onto two high resolution screens for full binocular vision. eSight Go users can personalize adjustable color and contrast settings on the internal-facing OLED screens.

A wider field of view (45 degrees) incorporates a user’s natural peripheral capacity to amplify existing vision for unmatched mobility. New features also include:

  • Improved software with simplified navigation and image stabilization
  • Higher quality camera with 12 megapixel resolution and 4k capability and full HD OLED monitors to provide users with the clearest picture possible
  • Comfortable neck battery pack that redistributes 170 grams across the neck

According to the company, eSight will be available on the market starting in Q4 2023. For tech spec sheets and more, visit the company’s website.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
© 2025 MJH Life Sciences

All rights reserved.